Share your thoughts, experiences and ideas which could help others.
Please, no commercial content and no spam.
Make sure you enter your email address correctly so we can let you know when it goes live after a short moderation process.
Alemtuzumab (marketed as Campath, MabCampath or Campath-1H and currently under further development as Lemtrada) is a monoclonal antibody used in the treatment of chronic lymphocytic leukemia (CLL), cutaneous T-cell lymphoma (CTCL) and non-Hodgkin lymphoma. It is also u...
Read more on Wikipedia
I was part of the clinical trial got treated for 2 years...at least one relapse. Lost some hair not a bunch, lost some weight, about 12 lbs. liked it because it was one full treatment cycle a year, so I was not getting treated as frequently as other meds.